Condensed Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 6,377,923	$ 12,710,762
Collaboration receivable		5,000,000
Prepaid expenses	920,710	1,094,229
Other current assets	5,436	9,283,625
Total current assets	7,304,069	28,088,616
Property and equipment, net	92,502	114,112
Other assets:
Goodwill	7,647,267	7,647,267
Other non-current assets	280,695	406,956
Total assets	15,324,533	36,256,951
Current liabilities:
Accounts payable	4,687,513	1,405,734
Accrued expenses	3,858,735	2,428,193
Deferred collaboration funding, current	10,598,201	15,825,938
Other current liabilities	138,721	9,450,085
Bridge loan payable, current, at fair value	1,510,571
Total current liabilities	20,793,741	29,109,950
Deferred collaboration funding, non-current		8,661,109
Bridge loan payable non-current, at fair value	2,967,788
Convertible note payable, at fair value	3,603,000
Other non-current liabilities	167,321	209,497
Total liabilities	27,531,850	37,980,556
Commitments and Contingencies (Note 8)
Stockholders’ deficit:
Preferred stock, $0.0001 par value; authorized 10,000,000 shares; none issued and outstanding
Common stock, $0.0001 par value; authorized 150,000,000 shares; 16,373,611 and 14,310,244 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	1,637	1,431
Additional paid-in capital	119,153,985	112,784,918
Accumulated deficit	(131,362,939)	(114,509,954)
Total stockholders’ deficit	(12,207,317)	(1,723,605)
Total liabilities and stockholders’ deficit	$ 15,324,533	$ 36,256,951